Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Public ClinicalTrials.gov record NCT01440751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this prospective randomised study is to compare the efficacy and safety of ologen CM (Collagen matrix) and Mitomycin-C (MMC) as adjuncts to filtration surgery in uncontrolled treated glaucoma cases, the efficacy being the primary objective and the safety being the secondary.
Study identification
- NCT ID
- NCT01440751
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- Use of ologen Collagen Matrix in trabeculectomy (ologen) Device
- Use of Mitomycin-C (MMC) in trabeculectomy Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Nov 1, 2017
2011 – 2015
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VoldVision-Holf Eye Clinic | Rogers | Arkansas | 72756 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Institue of Ophthalmology and Visual Science | Newark | New Jersey | 07103 | — |
| Glaucoma Associates of New York | New York | New York | 10003 | — |
| New York Eye and Ear Infirmary | New York | New York | 10003 | — |
| Dean McGee Eye Institue | Oklahoma City | Oklahoma | 73104 | — |
| Wills Eye Institue | Philadelphia | Pennsylvania | 19107 | — |
| Glaucoma Associates of Texas | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01440751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01440751 live on ClinicalTrials.gov.